[EN] HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES D'EGFR DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
申请人:BLUEPRINT MEDICINES CORP
公开号:WO2022271749A1
公开(公告)日:2022-12-29
The present disclosure provides a compound represented by structural formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer.
本公开提供一种化合物,其结构式表示为(I):或其药学上可接受的盐,用于治疗癌症。
Synthesis, crystal structures and spectral characterization of chiral 4-R-1,2,4-triazoles
作者:Il'ya A. Gural'skiy、Viktor A. Reshetnikov、Irina V. Omelchenko、Agnieszka Szebesczyk、Elzbieta Gumienna-Kontecka、Igor O. Fritsky
DOI:10.1016/j.molstruc.2016.07.094
日期:2017.1
4-triazoles that have been prepared by Bayer's synthesis from the corresponding aliphatic chiral amines. This approach tends to be universal towards different triazoles and permits to conserve a homochirality of substrates. Novel asymmetric molecules have been characterized by spectroscopic techniques and their structures have been retrieved from the single crystalX-ray analysis. Chiro-optical studies of these
摘要 1,2,4-三唑作为用于构建配位结构的常用药物和配体引起了人们的关注。在本文中,我们描述了四种光学活性 4-取代的 1,2,4-三唑,它们是通过拜耳合成法从相应的脂肪族手性胺制备的。这种方法往往适用于不同的三唑,并允许保留底物的同手性。新的不对称分子已通过光谱技术表征,其结构已从单晶 X 射线分析中恢复。这些杂环的手性光学研究已通过圆二色光谱法进行。